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With the launch of the first issue of *Hepatology Communications* in February 2017, the journal continues to publish monthly issues, is gaining recognition, and the number of new submissions is steadily increasing. While our new journal enjoys support from the community of hepatologists and the American Association for the Study of Liver Diseases (AASLD), we are frequently asked, "When will it be indexed in PubMed?" and "How soon will it receive an Impact Factor?". These are important considerations by authors who have various choices on where to submit their work.[1](#hep41153-bib-0001){ref-type="ref"} In this editorial, we describe the process and timeline for *Hepatology Communications* to be indexed in PubMed Central (PMC), MEDLINE, and the Science Citation Index Expanded (SCI \[E\]). The SCI (E) feeds into the Journal Citation Reports for Impact Factors; thus, it is important to the *Hepatology Communications* editorial team and to authors.

Standards and Requirements {#hep41153-sec-0002}
==========================

Each one of these databases has their respective standards and requirements that *Hepatology Communications* will have to meet.

STEP 1: FULL PARTICIPATION IN PMC {#hep41153-sec-0003}
---------------------------------

PMC is a full text archive, and citations for articles deposited in PMC are available on PubMed. Attaining full participation in PMC for any new journal is the first milestone in the indexing process. The PMC application requires that the journal has published at least 25 peer‐reviewed research articles.[2](#hep41153-bib-0002){ref-type="ref"} *Hepatology Communications* reached this milestone in June 2017, and we submitted our application shortly after. We are pleased to announce that the journal received full listing in PMC in December 2017.This means that our journal has met the scientific quality standards set by the National Institutes of Health and the National Library of Medicine (NLM). Points of consideration included the scientific and editorial scope and quality of the journal and the suitability of the journal for the NLM collection. Other elements included meeting the technical standards of the database, which included the need to provide high‐quality digital files from our publisher, Wiley.

STEP 2: INDEXING IN MEDLINE {#hep41153-sec-0004}
---------------------------

MEDLINE is the principal online bibliographic citation database of the NLM and provides the largest subset of PubMed articles. The minimum requirement for the MEDLINE application for a new journal is to have published for 12 months with at least 40 articles. Based on these criteria, *Hepatology Communications* will submit our MEDLINE listing application in March 2018. The MEDLINE evaluation team meets 3 times a year to consider applications, and the more content the journal has published, the stronger the application will be. Other considerations include sustainability in publishing quality content on a consistent schedule, the scope and coverage of the journal, quality of content and editorial work, and audience. MEDLINE also requires that all published articles include declarations of conflict of interest by authors, confirmation that informed consent was obtained for any human subject studies, and that animal welfare was taken into consideration.[3](#hep41153-bib-0003){ref-type="ref"}, [4](#hep41153-bib-0004){ref-type="ref"}

STEP 3: INDEXING IN WEB OF SCIENCE AND JOURNAL CITATION REPORTS {#hep41153-sec-0005}
---------------------------------------------------------------

The Web of Science indexes the most relevant and influential research articles in the world. We understand that our authors are eager to see the journal indexed in the Web of Science to ultimately receive an Impact Factor. Web of Science is now owned by Clarivate Analytics, and they evaluate submissions on a regular basis to ensure their database covers all topic areas producing high‐quality content. When evaluating a new journal like *Hepatology Communications* that has no or little citation history, Clarivate Analytics will examine the journal\'s contributing authors and editors and their citation history. After *Hepatology Communications* has published a sufficient volume of content to show that we have regular and consistent article flow and high‐quality standards, *Hepatology Communications* will apply to the Emerging Science Citation Index, a pre‐index of the SCI (E) in which journals can be indexed and visible in the Web of Science while they are evaluated for full indexing in the SCI (E). We anticipate applying early this year. Web of Science evaluations are conducted on an ongoing basis and take several months to come to a decision. Criteria for the Emerging Science Citation Index and SCI (E) indexing are provided in Table [1](#hep41153-tbl-0001){ref-type="table-wrap"}.[5](#hep41153-bib-0005){ref-type="ref"}, [6](#hep41153-bib-0006){ref-type="ref"}, [7](#hep41153-bib-0007){ref-type="ref"}, [8](#hep41153-bib-0008){ref-type="ref"}

###### 

Criteria Considered for Inclusion in Web of Science

  Emerging Science Citation Index                                                           Science Citation Index (Expanded)
  ----------------------------------------------------------------------------------------- ------------------------------------------------
  Conduct proper peer review                                                                Regular and timely publication
  Conform to ethical publishing practices                                                   Editorial board diversity
  Be of high interest to the scholarly community (and enrich the Web of Science database)   Subject relevance and strong editorial content
  Meet technical and electronic delivery requirements                                       Citation performance
  Self‐citation count less than 15%                                                         

Once *Hepatology Communications* is accepted in the SCI (E), the journal will be included in the Journal Citation Reports for an Impact Factor. Three years\' worth of content is required for a journal to receive an Impact Factor, and based on this, the earliest date for *Hepatology Communications* to receive an Impact Factor would be in 2020. All *Hepatology Communications* articles will be included back to the first issue.

Immediate Plans {#hep41153-sec-0006}
===============

While we are waiting on these upcoming decisions, the editorial team is focusing on important next steps to measure success.

First, we aim to increase the number of submissions both in primary submissions to *Hepatology Communications* and in the number of cascaded manuscript submissions from *Hepatology*. We are tracking submission trends and attracting new authors and author groups.

Second, we are applying rigorous peer review to all submissions received. Our associate editors take pride in an objective and fair review process. Invitations were recently sent to the newly formed Editorial Board, and their participation in the peer review process will further help to set high standards for the journal.

Third, we enjoy the security and reputation of the AASLD brand. In the era of ever increasing numbers of online journals, readers and authors of *Hepatology Communications* should be confident about the future of this new AASLD journal and the resources the society has dedicated to it. We hope that the demonstrated initial success of *Hepatology Communications* will convince authors to submit their work to our journal and join our effort to build a strong journal that AASLD and the broader hepatology community can rely on for advances in basic, clinical, and translational research and knowledge in hepatology.
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